Effector mechanism and clinical response of BAK (BRM-activated killer) immuno-cell therapy for maintaining satisfactory QOL of advanced cancer patients utilizing CD56-positive NIE (neuro-immune-endocrine) cells.
about
Effector mechanism and clinical response of BAK (BRM-activated killer) immuno-cell therapy for maintaining satisfactory QOL of advanced cancer patients utilizing CD56-positive NIE (neuro-immune-endocrine) cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Effector mechanism and clinica ...... neuro-immune-endocrine) cells.
@en
Effector mechanism and clinical response of BAK
@nl
type
label
Effector mechanism and clinica ...... neuro-immune-endocrine) cells.
@en
Effector mechanism and clinical response of BAK
@nl
prefLabel
Effector mechanism and clinica ...... neuro-immune-endocrine) cells.
@en
Effector mechanism and clinical response of BAK
@nl
P2093
P2860
P1476
Effector mechanism and clinica ...... neuro-immune-endocrine) cells.
@en
P2093
P2860
P304
P356
10.1111/J.1348-0421.2001.TB02638.X
P577
2001-01-01T00:00:00Z